I researched for quite some time, and feel I definitely made the right choice
NCT04847557) seeks to evaluate the effect of tirzepatide (is a dual agonist for the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors) over 52 weeks in 700 patients with heart failure with preserved ejection fraction (HFpEF) and obesity
Not recommended for children, pregnant or nursing women, or those sensitive to caffeine
The maintenance phase transitions to self-management with compression garments, continued exercise, and ongoing skin protection
Studies have shown that members of the ENT family-proteins ENT1, ENT2, and ENT4 can import extracellular NR and a broad range of similar compounds into cultured human cells
Rich & Indulgent Flavor Enjoy the decadent taste of chocolate and salted caramel in a GLP-1-friendly shake that supports your weight loss routine